AI Analysis AI Analysis of ANVS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ANVS to Watchlist?
Some Reasons Why To Add ANVS:
  • Highly efficient cash conversion (100% FCF/OCF ratio)
  • Beat earnings estimates in 2 of the last 4 quarters
  • Established player in the Healthcare sector
PDF

Green day on Thursday for Annovis Bio, Inc. stock after gaining 0.521%
(Updated on Jul 02, 2026)

Buy candidate since Jul 01, 2026 Gain 0.52%

The Annovis Bio, Inc. stock price gained 0.521% on the last trading day (Thursday, 2nd Jul 2026), rising from $1.92 to $1.93. During the last trading day the stock fluctuated 6.05% from a day low at $1.90 to a day high of $2.02. The price has risen in 6 of the last 10 days and is up by 10.92% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 232 thousand more shares were traded than the day before. In total, 941 thousand shares were bought and sold for approximately $1.82 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.78% during the next 3 months and, with a 90% probability hold a price between $1.30 and $2.10 at the end of this 3-month period.

ANVS Signals & Forecast

Mostly positive signals in the chart today. The Annovis Bio, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.81 and $1.89. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 16.97%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Annovis Bio, Inc. stock

Annovis Bio, Inc. finds support from accumulated volume at $1.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.115 between high and low, or 6.05%. For the last week, the stock has had daily average volatility of 5.97%.

Our recommended stop-loss: $1.86 (-3.82%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (ANVS) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Annovis Bio, Inc. to open at $1.95, and during the day (based on 14 day Average True Range), to move between $1.87 and $1.99, which gives a possible trading interval of +/-$0.123 (+/-6.57%) up or down from last closing price. If Annovis Bio, Inc. takes out the full calculated possible swing range there will be an estimated 6.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.86 (3.63%) than the resistance at $2.04 (5.70%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Annovis Bio, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.024 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $1.95 ( 0.95%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ANVS Performance

Trading levels for ANVS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.06 6.91%
R2 2.02 4.63%
R1 1.99 3.23%
Price 1.93
S1 1.90 -1.33%
S2 1.88 -2.73%
S3 1.83 -5.01%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.28 18.13%
R2 2.27 17.62%
R1 2.04 5.70%
Price 1.93
S1 1.86 -3.63%
S2 1.62 -16.06%
S3 1.59 -17.62%

FAQ

What is the symbol for Annovis Bio, Inc. Stock and on which exchange is it traded?
The symbol for Annovis Bio, Inc. is ANVS and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Annovis Bio, Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Annovis Bio, Inc. Stock?
Annovis Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Annovis Bio, Inc. Stock.

What's the current price of Annovis Bio, Inc. Stock?
As of the end of day on the Jul 02, 2026, the price of an Annovis Bio, Inc. (ANVS) share was $1.93.

What is the 52-week high and low for Annovis Bio, Inc. Stock?
The 52-week high for Annovis Bio, Inc. Stock is $5.50 and the 52-week low is $1.55.

What is the market capitalization of Annovis Bio, Inc. Stock?
As of the Jul 02, 2026, the market capitalization of Annovis Bio, Inc. is 37.97M.

When is the next earnings date for Annovis Bio, Inc.?
The upcoming earnings date for Annovis Bio, Inc. is Aug 18, 2026.
Click to get the best stock tips daily for free!
ABOUT ANNOVIS BIO, INC.
Annovis Bio
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for prote...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE